In conclusion, the present study showed that upregulation of NRP-1 led to increased tumor motility in radiation-surviving tumor cells, which could be suppressed by the treatment of anti-NRP-1 antibody to a greater extent than the tumor cells before irradiation. The gene discussed is NRP1; the disease is neoplasm.